Oncopeptides AB (publ) (STO:ONCO)
Sweden
· Delayed Price · Currency is SEK 1.890
-0.010 (-0.53%)
May 6, 2025, 11:51 AM CET
Oncopeptides AB Revenue
In the year 2024, Oncopeptides AB had annual revenue of 31.65M SEK, down -10.14%. Oncopeptides AB had revenue of 9.91M in the quarter ending December 31, 2024, with 85.76% growth.
Revenue
31.65M
Revenue Growth
-10.14%
P/S Ratio
12.92
Revenue / Employee
395.60K
Employees
80
Market Cap
408.85M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 997.85M |
Oncopeptides AB News
- 6 months ago - Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market ... - GuruFocus
- 6 months ago - Q3 2024 Oncopeptides AB Earnings Call Transcript - GuruFocus
- 9 months ago - Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and ... - GuruFocus
- 9 months ago - Q2 2024 Oncopeptides AB Earnings Call Transcript - GuruFocus